| Literature DB >> 36245516 |
Yongshuai Jing1, Shilin Zhang1, Mingsong Li1, Ruijuan Zhang1, Hao Zhang1, Yuguang Zheng2, Danshen Zhang1, Lanfang Wu2.
Abstract
Iron deficiency anemia can lead to a variety of functional disorders, which is one of the highest incidence of nutrient deficiency diseases. The direct addition of iron to food will not only brings difficulties to the production of products, but also brings damages to human body. In recent years, international studies have shown that polysaccharide iron complex (PIC) not only has a variety of pharmacological activities of polysaccharide itself, but also has the function of supplementing iron, so it is a good iron supplement. With the advantages of good solubility, high iron content, low gastrointestinal irritation and high bioavailability, PIC is an effective iron supplement for iron deficiency anemia and has attracted more and more attention. In this paper, the different preparation methods, structural characterization, biological activities and clinical applications of PIC synthesized by natural polysaccharides from plant were reviewed, in order to provide theoretical basis for the development and application of PIC.Entities:
Keywords: biological activities; clinical application; polysaccharide iron complex; preparation methods; structural characterization
Year: 2022 PMID: 36245516 PMCID: PMC9561936 DOI: 10.3389/fnut.2022.1013067
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
Figure 1Overall research idea chart of PIC.
Figure 2Preparation of PIC by ferric chloride co thermal synthesis.
Main reaction conditions for preparation of PIC by ferric chloride co thermal synthesis.
|
|
|
| ||
|---|---|---|---|---|
| 1 |
| The optimum synthesis conditions for CPPI were pH 8.9, temperature 70.30°C and the ratio of citric acid to CPPI of 2.95. | 28.40 | ( |
| 2 |
| Chelation time was 5.5 h, the mass ratio of HMP to iron (III) was 4.5:1 (mg/mg), initial mass concentration of iron (III) was 5.2 mg/mL and pH was 2.1. | 86.69 | ( |
| 3 |
| The reaction temperature 60°C, pH 8.51, reaction time 1 h and sodium citrate to Taraxacum polysaccharides was 0.50. | 24.0–41.0 | ( |
| 4 |
| The reaction temperature 70°C, pH 8.00, reaction time 2 h and sodium citrate to | 15.7 | ( |
| 5 |
| The reaction temperature 70°C, pH 7–8, reaction time 1 h and sodium citrate to P | 15.08 | ( |
| 6 | The reaction temperature 80°C, pH 8.0, reaction time 1.05 h and sodium citrate to | 16.03 | ( | |
| 7 |
| The ratio of IOPS and FeCl3•6H2O was 3:5 (w/w), the pH value of alkali solution was 10, the reaction temperature was 30°C and the reaction time was 6 h. | 19.40 | ( |
| 8 |
| The reaction temperature 89.46°C, pH 8.16, reaction time 46.04 min and ratio of catalyst to APS 0.75. | 21.08–21.24 | ( |
| 9 |
| The reaction temperature 70°C, pH 8.51, reaction time 2 h and sodium citrate to | 22.63–28.67 | ( |
| 10 | Soybean | The reaction temperature 68.9°C, pH 8.89, reaction time 1.47 h and sodium citrate to SSPS was 0.52. | 14.53–15.61 | ( |
| 11 |
| The reaction temperature 60°C, pH 8.56, reaction time 1 h and sodium citrate to PEs was 0.15. | 20.71–20.99 | ( |
Related research results of determination method of iron content in PIC.
|
|
|
|
| |
|---|---|---|---|---|
| O-phenanthroline spectrophotometry | ABMP-Fe (III) |
| 16.24 ± 0.44% | ( |
| TP-Fe (III) |
| 22.7% | ( | |
| MP-Fe (III) | Maca | 13.31% | ( | |
| MFP-Fe (III) |
| 2.9–4.9% | ( | |
| PPI |
| 30.76% | ( | |
| Atomic absorption spectrometry | GLP-Fe (III) |
| 13.22% | ( |
| LBP-Fe (III) |
| 36.71 mg/ml | ( | |
| EPP-Fe (III) |
| 19.6% | ( | |
| LBP-Fe (III) |
| 36.71 mg/g | ( | |
| SMP-Fe (III) |
| 269.14 mg/g | ( | |
| ZJSP-Fe (III) |
| 21.7% | ( | |
| UPP-iron (III) |
| 25.65 ± 3.02% | ( | |
| SUE-iron (III) |
| 20.3% | ( | |
| Replacement iodometry | POPFe |
| 30.13% | ( |
| CP-Fe (III) | Corn | 39.86–40.17% | ( | |
| FTP-Fe (III) |
| 28.5–29.7% | ( |
Figure 3Diagram of iron and phenanthroline reaction.
In vitro antioxidant activity indexes and research results of PIC.
|
|
|
| |
|---|---|---|---|
| GP-Fe (III) |
| DPPH: Vc(Kmax≈90.13%)>PS-Fe(Kmax≈21.15%)>PS(Kmax≈17.16%) | ( |
| Xyl-Fe (III) | Xylan | DPPH: Vc(Kmax≈90.12%)>Xyl-Fe(Kmax=73.44%)>Xyl(Kmax≈39.85%) | ( |
| SP-Fe (III) | Seaweed algae | •OH: SP-Fe(-)>SP(-) | ( |
| FUP-Fe (III) |
| DPPH: Vc(Kmax≈93.12%)>FUP-Fe(Kmax=68.96%)>FUP(Kmax≈42.15%) | ( |
| SP-Fe (III) |
| DPPH: Vc(EC50=0.018 g/L)>SP-Fe(EC50=1.480 g/L)>SP(EC50=2.840 g/L) | ( |
| GFP-Fe (III) |
| DPPH: Vc(EC50=0.004 mg/mL)>GFP(EC50=0.653 mg/mL)>GFP-Fe(EC50=3.123 mg/mL) | ( |
| APS-Fe (III) |
| DPPH: APS(EC50=0.4805 mg/mL)>APS-Fe(EC50=2.2739 mg/mL) | ( |
| GLP-80-Fe (III) |
| DPPH: Vc(IC50=0.005 mg/mL)>GFP-Fe(IC50=3.79 mg/mL)>GFP(IC50=9.06 mg/mL) | ( |
1,1-diphenyl-2-picrylhydrazyl radical (•DPPH); hydroxyl radical (•OH); superoxide anion radical (); 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) radical (ABTS+•); concentration for 50% of maximal effect (EC50); median inhibition concentration (IC50).
Figure 4Analysis of 108,797 patents browsed in www.lens.org using the search terms “Polysaccharide iron complex”: (A) patent applications per years; (B) document type; (C) jurisdictions (WO-WIPO, world intellectual property organization); (D) central product classification.